CONMED Corporation
CNMD · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,111 | $3,358 | $2,663 | $4,134 |
| - Cash | $24 | $24 | $29 | $21 |
| + Debt | $906 | $991 | $1,055 | $685 |
| Enterprise Value | $2,992 | $4,325 | $3,689 | $4,798 |
| Revenue | $1,307 | $1,245 | $1,045 | $1,011 |
| % Growth | 5% | 19.1% | 3.4% | – |
| Gross Profit | $733 | $676 | $571 | $568 |
| % Margin | 56.1% | 54.3% | 54.6% | 56.2% |
| EBITDA | $272 | $192 | $8 | $179 |
| % Margin | 20.8% | 15.5% | 0.7% | 17.7% |
| Net Income | $132 | $64 | -$81 | $63 |
| % Margin | 10.1% | 5.2% | -7.7% | 6.2% |
| EPS Diluted | 4.26 | 2.04 | -2.68 | 1.94 |
| % Growth | 108.8% | 176.1% | -238.1% | – |
| Operating Cash Flow | $167 | $125 | $33 | $112 |
| Capital Expenditures | -$13 | -$19 | -$22 | -$15 |
| Free Cash Flow | $154 | $106 | $12 | $97 |